Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
69.69
+0.39 (0.56%)
Feb 3, 2026, 1:25 PM CST
Shanghai Haoyuan Chemexpress Company Description
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.
The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds.
The company was founded in 2006 and is headquartered in Shanghai, China.
Shanghai Haoyuan Chemexpress Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,826 |
| CEO | Baofu Zheng |
Contact Details
Address: No. 3 Building Shanghai, 201203 China | |
| Phone | 86 21 5899 8590 |
| Website | chemexpress.cn |
Stock Details
| Ticker Symbol | 688131 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000051J4 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Baofu Zheng | Chairman and GM |
| Min Li | Chief Financial Officer and Accounting Supervisor |
| Qiang Gao | Deputy GM and Director |
| Weihong Shen | Board Secretary |
| Zhiguo Zhou | Core Technical Staff |
| Kuei Mei | Core Technical Staff |